Evidence map›Paper›PMID 29691449›Full record

ArticleScientific reports2018

Author Correction: Virtual screening for inhibitors of the human TSLP:TSLPR interaction.

Dries Van Rompaey, Kenneth Verstraete, Frank Peelman, Savvas N Savvides, Koen Augustyns, Pieter Van Der Veken, Hans De Winter

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dries Van RompaeyLaboratory of Medicinal Chemistry, University of Antwerp, 2610, Wilrijk, Belgium.
Kenneth VerstraeteLaboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, Ghent University, 9000, Ghent, Belgium.
Frank PeelmanVIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Savvas N SavvidesLaboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, Ghent University, 9000, Ghent, Belgium.
Koen AugustynsLaboratory of Medicinal Chemistry, University of Antwerp, 2610, Wilrijk, Belgium.ORCID http://orcid.org/0000-0002-5203-4339
Pieter Van Der VekenLaboratory of Medicinal Chemistry, University of Antwerp, 2610, Wilrijk, Belgium.
Hans De WinterLaboratory of Medicinal Chemistry, University of Antwerp, 2610, Wilrijk, Belgium. hans.dewinter@uantwerpen.be.
University of Antwerp · BEGhent University · BEVIB-UGent Center for Medical Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Identifiers

PMID29691449
PMCPMC5915381
OpenAlexW2799750027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.